Answers are grounded in this paper and cite their sources.
Objectives: To describe the clinical and paraclinical characteristics of patients with CMV disease at the National Hospital for Tropical Diseases.Subjects and methods: Retrospective combined with a prospective cohort study on 58 patients diagnosed with CMV disease treated at the National Hospital of Tropical Diseases in 2 years from January 2020 to June 2022.Results: In a total of 58 patients with CMV disease, 56.9% of patients were male and the mean age was 45.57 ± 15.7 years. HIV (55.17%), history of prolonged corticoid therapy (20.7%), diabetes (10.34%), alcoholism (3.45%), transplantation (1.72%) were major comorbidities. Common clinical symptoms were:fever (74.13%), low visual acuity (37.93%), weight loss (31.03%), productive cough (31.03%), headache(27.59%), lymphadenopathy (24.14%), dry cough (22.41%). 43.1% had monocytosis status, most patientshad normal white blood cell (WBC) count, and slightly increased inflammation markers (ESR, CRP, PCT).The interquartile range of T-CD4 was48 (11.75 - 215), and 60% of patients had T-CD4 countless than 100cells/µL. There was no difference between two groups of HIV and non-HIV patients in sex ratio. The HIVgroup had higher mean age than non-HIV. Low visual acuity, lymphadenopathy, and weight loss were more frequent in the HIV group, and liver damage was only seen in the non-HIV group.Conclusion: The study showed that the clinical and paraclinical signs of CMV disease are diverse, nonspecific and need to be considered for screening in patients with suspected symptoms with a history of HIV, prolonged corticoid, diabetes, alcoholism, or transplantation.
No takes yet. Share an insight, caveat, or question.
Duong et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: